Emily J Gianatti
Overview
Explore the profile of Emily J Gianatti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
146
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hudson J, Cruickshank M, Quinton R, Aucott L, Wu F, Grossmann M, et al.
Lancet Healthy Longev
. 2023 Oct;
4(10):e561-e572.
PMID: 37804846
Background: Testosterone replacement therapy is known to improve sexual function in men younger than 40 years with pathological hypogonadism. However, the extent to which testosterone alleviates sexual dysfunction in older...
2.
Hudson J, Cruickshank M, Quinton R, Aucott L, Aceves-Martins M, Gillies K, et al.
Lancet Healthy Longev
. 2022 Jun;
3(6):e381-e393.
PMID: 35711614
Background: Testosterone is the standard treatment for male hypogonadism, but there is uncertainty about its cardiovascular safety due to inconsistent findings. We aimed to provide the most extensive individual participant...
3.
Latino C, Gianatti E, Mehta S, Lo J, Devine A, Christophersen C
BMC Pregnancy Childbirth
. 2022 Jan;
22(1):46.
PMID: 35042457
Background: Gestational Diabetes Mellitus (GDM) is prevalent with lasting health implications for the mother and offspring. Medical nutrition therapy is the foundation of GDM management yet achieving optimal glycaemic control...
4.
Gianatti E, Hoermann R, Lam Q, Dupuis P, Zajac J, Grossmann M
Clin Endocrinol (Oxf)
. 2015 Jun;
84(1):55-62.
PMID: 26120052
Objective: To assess the effect of testosterone treatment on cardiac biomarkers in men with type 2 diabetes (T2D). Design: Randomized double-blind, parallel, placebo-controlled trial. Patients: Men aged 35-70 years with...
5.
Gianatti E, Hoermann R, Grossmann M
Diabetes Care
. 2014 Nov;
37(12):e269.
PMID: 25414403
No abstract available.
6.
Gianatti E, Dupuis P, Hoermann R, Zajac J, Grossmann M
J Clin Endocrinol Metab
. 2014 Jul;
99(10):3821-8.
PMID: 24978674
Objective: The objective of the study was to assess the effect of T treatment on constitutional and sexual symptoms in men with type 2 diabetes (T2D). Design: This was a...
7.
Gianatti E, Dupuis P, Hoermann R, Strauss B, Wentworth J, Zajac J, et al.
Diabetes Care
. 2014 May;
37(8):2098-107.
PMID: 24804695
Objective: To determine whether testosterone therapy improves glucose metabolism in men with type 2 diabetes (T2D) and lowered testosterone. Research Design And Methods: We conducted a randomized, double-blind, parallel, placebo-controlled...
8.
Gani L, Gianatti E, Cheung A, Jerums G, MacIsaac R
J Med Case Rep
. 2011 Aug;
5:405.
PMID: 21861919
Introduction: The diagnostic efficacy of biochemical and imaging modalities for investigating the causes of Cushing's syndrome are limited. We report a case demonstrating the limitations of these modalities, especially the...
9.
Grossmann M, Gianatti E, Zajac J
Curr Opin Endocrinol Diabetes Obes
. 2010 Apr;
17(3):247-56.
PMID: 20418720
Purpose Of Review: To describe the relationship between testosterone levels and type 2 diabetes (T2D). Recent Findings: Multiple epidemiological studies have shown that low testosterone levels are associated with and...